A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/20/2011	US8080703 Dressing
12/20/2011	US8080586 Self-emulsifying preparations
12/20/2011	US8080553 Methods and reagents for the treatment of immunoinflammatory disorders
12/20/2011	US8080535 Hyaluronic acid nutritional supplements and methods of using the same
12/20/2011	US8080530 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
12/20/2011	US8080521 Flowable carrier matrix and methods for delivering to a patient
12/20/2011	US8080431 Nanoparticles
12/20/2011	US8080263 Dispersion for pulmonary delivery of a bioactive agent
12/20/2011	US8080262 Encapsulated peptide amphiphile nanostructures
12/20/2011	US8080261 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
12/20/2011	US8080259 Sustained delivery of an active agent using an implantable system
12/20/2011	US8080236 Particulate materials
12/20/2011	US8080097 System and a method for the creation of edible, optically invisible images
12/20/2011	US8080003 Method and implantable apparatus for the intra-osseal monitoring of biological substances in the bone marrow
12/20/2011	US8080002 Implantable drug delivery device
12/20/2011	CA2733294C Pharmaceutical combination of a tiotropium salt and ciclesonide
12/20/2011	CA2540174C Aerosol formulation for inhalation, containing an anticholinergic agent
12/20/2011	CA2535664C Disinfecting and sanitizing article for hands and skin and hard surfaces
12/20/2011	CA2530619C Non-gelatin film and method and apparatus for producing same
12/20/2011	CA2524665C Drug delivery system
12/20/2011	CA2464660C Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
12/20/2011	CA2427388C Pharmaceutical compositions and uses for improving memory and learning impairments
12/20/2011	CA2303394C A delivery of arginine to cause beneficial effects
12/15/2011	WO2011156711A1 Nanoparticle film delivery systems
12/15/2011	WO2011156578A1 Solid compositions
12/15/2011	WO2011156481A2 Formulations including amiodarone and salts thereof and methods of their manufacture and use
12/15/2011	WO2011156405A2 Oral spray formulations and methods for administration of sildenafil
12/15/2011	WO2011156388A1 Cyclopropene compositions
12/15/2011	WO2011156361A2 Solid dispersions containing kinase inhibitors
12/15/2011	WO2011156242A2 Improved anti-lysophospholipid antibody design using antibody structures
12/15/2011	WO2011156119A1 Combination therapy methods for treating proliferative diseases
12/15/2011	WO2011156045A2 Tablet formulation of ezatiostat
12/15/2011	WO2011156030A2 High oil-content emollient aerosol foam compositions
12/15/2011	WO2011155686A1 Method of preparaing enteric hard capsule and enteric hard capsule prepared thereby
12/15/2011	WO2011155640A1 Antimycotic pharmaceutical composition
12/15/2011	WO2011155501A1 Pharmaceutical multimeric particles, and manufacturing method for same
12/15/2011	WO2011155451A1 Coated particle and method for producing coated particle
12/15/2011	WO2011154985A1 Ophthalmic compositions for the administration of liposoluble acitve ingredients
12/15/2011	WO2011154975A2 Pharmaceutical compositions of metformin
12/15/2011	WO2011154941A2 Multiple-layer immune barrier for donor cells
12/15/2011	WO2011154916A1 5-ala ester formulations and use thereof
12/15/2011	WO2011154725A2 Compositions
12/15/2011	WO2011154724A2 Compositions
12/15/2011	WO2011154497A1 Treatment of type 2 diabetes
12/15/2011	WO2011154496A1 Treatment of type 1 diabetes
12/15/2011	WO2011154444A1 Novel process
12/15/2011	WO2011154443A1 Novel process
12/15/2011	WO2011154421A1 Microcapsules containing active substance and having a metal oxide-containing shell
12/15/2011	WO2011154418A1 Preparation for vaginal and rectal use and relative production method
12/15/2011	WO2011154414A1 Diversion-resistant microgranules and microtablets
12/15/2011	WO2011154118A1 Quetiapine prolonged-release tablets
12/15/2011	WO2011154014A1 Controlled humidity drying
12/15/2011	WO2011154013A1 Pharmaceutical composition comprising fenofibric acid
12/15/2011	WO2011154012A1 Mini-tablets comprising porous adsorbent material
12/15/2011	WO2011154009A1 Composition comprising an active principle in an amorphous form and a porous adsorbent material
12/15/2011	WO2011154004A1 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
12/15/2011	WO2011129549A9 Anticancer drug delivery system using ph-sensitive metal nanoparticles
12/15/2011	WO2011120929A3 Animal feed for calves for conditioning the intestinal flora
12/15/2011	WO2011107466A3 Melt-coated pharmaceutical forms
12/15/2011	WO2011100425A3 Methods and compositions for wound healing
12/15/2011	WO2011097384A3 Tumor targeted delivery of immunomodulators by nanoplymers
12/15/2011	WO2011093833A3 Effervescent formulations comprising second generation cephalosporin
12/15/2011	WO2011093832A3 Stable efervescent formulations comprising cefaclor
12/15/2011	WO2011093826A3 Effervescent formulations comprising cefaclor and clavulanic acid as active agents
12/15/2011	WO2011093823A3 Effervescent formulations comprising cefaclor and clavulanic acid
12/15/2011	WO2011091065A3 Synthetic nanostructures including nucleic acids and/or other entities
12/15/2011	WO2011056532A3 Bazedoxifene formulations with antioxidants
12/15/2011	WO2011034551A3 Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
12/15/2011	WO2011022737A3 Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
12/15/2011	WO2011016881A3 An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
12/15/2011	WO2011009603A8 Tamper-resistant dosage form for oxidation-sensitive opioids
12/15/2011	WO2011008770A3 Methods for inhibiting yellow color and peroxide formation in a composition
12/15/2011	WO2010145849A3 Drug delivery systems
12/15/2011	WO2010124203A3 Agglomerate formulations including active pharmaceutical agents with targeted particle sizes
12/15/2011	US20110307054 Implant coating with nucleic acids
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011	US20110306582 Androgen pharmaceutical composition and method for treating depression
12/15/2011	US20110306501 Active ingredient-comprising microcapsules with a metal oxide-containing shell
12/15/2011	US20110306500 Method of Treating a Material Using a Sol-gel Derived Composition
12/15/2011	US20110306018 Methods For Improving Pregnancy Outcomes
12/15/2011	US20110305782 Methods of cholesterol reduction using isoflavones
12/15/2011	US20110305775 Micronutrient Supplement Dispensing Package
12/15/2011	US20110305770 Releasable polymeric lipids for nucleic acids delivery system
12/15/2011	US20110305769 Branched cationic lipids for nucleic acids delivery system
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305767 Polymer Particles Prepared From Polymerisable Alkylene Glycol (Meth) Acrylate Monomers
12/15/2011	US20110305766 Method for Controlled Release of Parathyroid Hormone from Encapsulated Poly(Lactic-Glycolic)Acid Microspheres
12/15/2011	US20110305765 Preparation and methodology of silk fibroin nanoparticles
12/15/2011	US20110305764 Use of a Mare's Milk Concentrate Dried on a Highly-Dispersed, Biologically Inert Matrix
12/15/2011	US20110305763 Lantibiotics and uses thereof
12/15/2011	US20110305762 Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
12/15/2011	US20110305761 Polymersomes, colloidosomes, liposomes, and other species associated with fluidic droplets
12/15/2011	US20110305760 Tissue regeneration system
12/15/2011	US20110305759 composition comprising calcium carbonate as a white pigment
12/15/2011	US20110305758 Orally disintegrating tablet having inner core
12/15/2011	US20110305757 New pharmaceutical combinations
12/15/2011	US20110305756 Coated solid preparation
12/15/2011	US20110305755 Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
12/15/2011	US20110305754 Controlled release micro-capsule for osteogenic action

1 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 ... 2991